1,069
Participants
Start Date
October 13, 2016
Primary Completion Date
August 28, 2020
Study Completion Date
March 31, 2026
Lenvatinib
Everolimus
Pembrolizumab
Sunitinib
Institut Jules Bordet, Brussels
AKH - Medizinische Universität Wien, Vienna
ZNA Middelheim, Antwerp
GZA Ziekenhuizen - Campus Sint-Augustinus, Wilrijk
Austin Health, Heidelberg
Box Hill Hospital, Box Hill
Jessa Ziekenhuis - Campus Virga Jesse, Hasselt
Domaine Universitaire, Liège
Boulevard du Professeur Jacques Monod, Saint-Herblain
Hospital San Pedro de Alcantara, Cáceres
Weill Cornell Medical College New York Presbyterian Hospital, New York
Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center, The Bronx
"General Hospital of Athens Alexandra", Athens
EISAI Trial site 5, Berlin
Broome Oncology, Johnson City
Rosewell Park Cancer Institute, Buffalo
Istituto Nazionale per la Ricerca sul Cancro di Genova, Genova
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Associates in Oncology & Hematology, PC, Bethesda
Centre Georges François Leclerc, Dijon
University of Patras Medical School, Pátrai
Hospital Universitario Ramon y Cajal, Madrid
Mission Hospital_ Cancer Care of Western North Carolina, Asheville
Medical University of South Carolina, Charleston
EISAI Trial site 8, Hanover
Florida Hospital Cancer Institute, Orlando
Hospital Universitario Central de Asturias, Oviedo
University of Miami, Miami
Mount Sinai Medical Center, Miami Beach
Azienda Ospedaliera Santa Maria Degli Angeli, Pordenone
Florida Cancer Specialists, West Palm Beach
Boca Raton Community Hospital, Boca Raton
Florida Cancer Specialists ( North Region), St. Petersburg
Florida Cancer Specialists, Fort Myers
SCRI - Tennessee Oncology, Nashville
Hospital Universitario Marques de Valdecilla, Santander
A.O.U. Policlinico di Modena, Modena
Kyungpook National University Chilgok Hospital, Daegu
Oncology Hematology Care, Cincinnati
Oncologia, Valencia
Azienda Unità Sanitaria Locale- Ravenna, Faenza
EISAI Trial site 13, Münster
Karmanos Cancer Center, Detroit
ICO - Site Paul Papin, Angers
Rabin Medical Center-Beilinson Campus, Petah Tikva
General Hospital Papageorgiou, Thessaloniki
Interbalkan Hospital of Thessaloniki, Thessaloniki
Joliet Oncology - Hematology Associates, Joliet
Healthcare Research Network III, LLC, Tinley Park
EISAI Trial site 6, Frankfurt am Main
Health Midwest Ventures Group, Inc d/b/a HCA MidAmerica Division, LLC, Overland Park
EISAI Trial site 2, Homburg/Saar
Cotton-Oneil Clinical Research Center, Topeka
GU Research Network, Omaha
Nebraska Cancer Specialists, Omaha
Ochsner Clinic Foundation, New Orleans
EISAI Trial site 4, Stuttgart
EISAI Trial site 1, Tübingen
Presidio Ospedaliero Vito Fazzi, Lecce
Texas Oncology, P.A., Dallas
Texas Oncology PA - Paris, Paris
Texas Oncology PA - Tyler, Tyler
Texas Oncology PA, Fort Worth
USOR Texas Oncology, The Woodlands
Texas Oncology PA - McAllen, McAllen
Azienda Ospedaliera di Rilievo Nazionale A. Cardarelli, Napoli
EISAI Trial site 7, München
FSBSI Russian Oncological Scientific Center n.a. N.N. Blokhin - Department of Oncology, Moscow
"FSBI Moscow scientific research oncology institute n.a. P.A. Gertsen of MoH of RF", Moscow
"FSBI National Medical Research Radiological Center of the MoH of the RF", Obninsk
"SBHI of Novosibirsk region Novosibirsk Regional Oncological Dispensary", Novosibirsk
"BHI of Omsk region Clinical Oncology Dispensary", Omsk
Stanford School of Medicine, Stanford
Massachusetts General Hospital- MGH, Boston
Dana Farber Cancer Institute, Boston
Hackensack Medical Center, Hackensack
Royal Hobart Hospital, Hobart
Macquarie University Hospital, Macquarie Park
ICON Cancer Foundation, South Brisbane
Sunshine Hospital, St Albans
Medizinische Universitat Innsbruck, Innsbruck
Krankenhaus der barmherzigen Schwestern Linz, Linz
O.L.V Ziekenhuis, Aalst
Imeldaziekenhuis, Bonheiden
Fakultni nemocnice u sv. Anny v Brne, Brno
Masarykuv onkologicky ustav, Brno
Fakultni nemocnice Olomouc, Neurologicka klinika, Olomouc
Fakultni nemocnice v Motole, Prague
Nemocnice Na Bulovce, Prague
Thomayerova nemocnice, Prague
Clinique Victor Hugo - Centre Jean Bernard, Le Mans
Centre Leon Berard - Centre regional de lutte contre le cancer Rhone-Alpes, Lyon
Institut Regional du Cancer de Montpellier, Montpellier
Hopital Europeen Georges Pompidou, Paris
CHU Strasbourg - Nouvel Hopital Civil, Strasbourg
EISAI Trial site 14, Greifswald
Cork University Hospital,Wilton, Cork
Adelaide and Meath Hospital Incorp The National Children's Hospital, Dublin
Beaumont Hospital, Dublin
University Hospital Galway, Galway
Assaf Harofeh Medical Center, Be’er Ya‘aqov
Rambam MC, Haifa
Sapir Medical Center, Meir Hospital, Kfar Saba
Chaim Sheba Medical Center, Ramat Gan
Tel Aviv Sourasky Medical Center, Tel Aviv
Ospedale San Donato, Arezzo
Azienda Ospedaliera Universitaria Policlinico SantOrsola Malpighi, Bologna
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST, Meldola
Istituto Nazionale Tumori Fondazione G. Pascale, Napoli
Fondazione IRCCS Policlinico San Matteo, Pavia
I.R.C.S.S Fondazione Maugeri, Pavia
Azienda Ospedaliera San Camillo Forlanini, Roma
Universita Campus Bio-Medico di Roma, Rome
Facility #1, Aichi
Facility #1, Akita
Facility #1, Aomori
Facility #2, Chiba
Facility #1, Fukuoka
Facility #1, Hiroshima
Facility #1, Hokkaido
Facility #2, Hokkaido
Facility #1, Hyōgo
Facility #1, Kagawa
Facility #2, Kanagawa
Facility #3, Kanagawa
Facility #1, Nagasaki
Facility #1, Nara
Facility #1, Niigata
Facility #1, Okayama
Facility #1, Osaka
Facility #2, Osaka
Facility #1, Saitama
Facility #1, Tokushima
Facility #1, Tokyo
Facility #2, Tokyo
Facility #3, Tokyo
Facility #4, Tokyo
Facility #5, Tokyo
Facility #6, Tokyo
Uniwersyteckie Centrum Kliniczne, Gdansk
Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie, Lublin
SPWSZ w Szczecinie im. Marii Sklodowskiej-Curie, Szczecin
FSBSI Russian Oncological Scientific Center n.a. N.N. Blokhin - Department of Urology, Moscow
FBHI Privolzhskiy District Medical Centre FMBA of Russia, Nizhny Novgorod
National Cancer Center, Goyang-si
Asan Medical Center: Medical Oncology Department, Seoul
Asan Medical Center: Urology Department, Seoul
Department of Internal Medicine Division of Hematology/Oncology Cancer center 11F, Seoul
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
Hospital de la Santa Creu i Sant Pau, Barcelona
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Universitario Reina Sofia, Córdoba
Hospital General Universitario Gregorio Maranon, Madrid
Hospital Universitario Clinico San Carlos, Madrid
Hospital Universitario HM Madrid Sanchinarro, Madrid
MD Anderson Cancer Centre, Madrid
Hospital Universitario Virgen del Rocio, Seville
Inselspital - Universitaetsspital Bern, Bern
Royal Bournemouth General Hospital, Bournemouth
Velindre Cancer Centre, Cardiff
Western General Hospital, Edinburgh
Guy's Hospital, London
Royal Free Hospital, London
Cross Cancer Institute, Edmonton
BC Cancer Agency Vancouver Centre, Vancouver
St. Joseph's Healthcare Hamilton, Hamilton
London Institute of Health Sciences, London
Ottawa Hospital Cancer Centre, Ottawa
Sunnybrook Research Institute - University of Toronto, Toronto
Centre de santé et de services sociaux Champlain-Charles-Le Moyne, Greenfield Park
Hopital la Petie Salpetriere, Paris
Antoni van Leeuwenhoek, Amsterdam
VU Medisch Centrum, Amsterdam
UMC Utrecht, Utrecht
Hospital Clinic i Provincial de Barcelona, Barcelona
ICO l'Hospitalet - Hospital Duran I Reynals, Barcelona
Beatson West Of Scotland Cancer Centre, Glasgow
St. James's University Hospital, Leeds
Christie Hospital NHS Foundation Trust, Manchester
Merck Sharp & Dohme LLC
INDUSTRY
Eisai Inc.
INDUSTRY